Decreased insulin sensitivity, increased ovarian oxidative stress, altered serum estradiol and progesterone levels, and ovarian immunosuppressor prostaglandin E were also apparent in prepubertal hyperandrogenism after DHEA treatment (Luchetti et al. 2004, Elia et al. 2006). The gene discussed is INS; the disease is hyperandrogenism.